Nutex Health, Inc. financial data

Symbol
NUTX on Nasdaq
Location
6030 S. Rice Ave., Suite C, Houston, TX
Fiscal year end
December 31
Latest financial report
10-Q - Q1 2025 - May 13, 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 203 % +32.3%
Quick Ratio 2.41 % -49.2%
Debt-to-equity 351 % -19.9%
Return On Equity 42.1 %
Return On Assets 11.8 %
Operating Margin 32.3 %

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 5.53M shares -99.3%
Common Stock, Shares, Outstanding 5.53M shares +11.2%
Entity Public Float 18.2M USD -87.5%
Common Stock, Value, Issued 6K USD +20%
Weighted Average Number of Shares Outstanding, Basic 5.52M shares +13.8%
Weighted Average Number of Shares Outstanding, Diluted 5.85M shares +20.7%

Income Statement

Label TTM Value / Value Unit Change %
Revenues 624M USD +141%
General and Administrative Expense 43.3M USD +24.7%
Costs and Expenses 320M USD +46.3%
Operating Income (Loss) 201M USD +4880%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest 173M USD
Income Tax Expense (Benefit) 32.6M USD +4654%
Net Income (Loss) Attributable to Parent 67.2M USD
Earnings Per Share, Basic 13 USD/shares
Earnings Per Share, Diluted 12 USD/shares

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 43.6M USD +98.1%
Accounts Receivable, after Allowance for Credit Loss, Current 62.7M USD +17.9%
Inventory, Net 3.12M USD +4.79%
Assets, Current 402M USD +300%
Deferred Income Tax Assets, Net 10.5M USD
Operating Lease, Right-of-Use Asset 27.5M USD +137%
Intangible Assets, Net (Excluding Goodwill) 15.2M USD -24.4%
Goodwill 13.9M USD -18.4%
Assets 762M USD +88.5%
Accounts Payable, Current 19.8M USD +15.2%
Liabilities, Current 177M USD +195%
Deferred Income Tax Liabilities, Net 3.4M USD -59.9%
Operating Lease, Liability, Noncurrent 30.4M USD +101%
Liabilities 487M USD +50.2%
Retained Earnings (Accumulated Deficit) -342M USD +16.4%
Stockholders' Equity Attributable to Parent 197M USD +213%
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest 275M USD +244%
Liabilities and Equity 762M USD +88.5%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities 51M USD +1570%
Net Cash Provided by (Used in) Financing Activities -6.81M USD -220%
Net Cash Provided by (Used in) Investing Activities -64K USD +91.3%
Common Stock, Shares Authorized 950M shares 0%
Common Stock, Shares, Issued 5.53M shares -88.9%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Interest Paid, Excluding Capitalized Interest, Operating Activities 608K USD +10.9%
Deferred Tax Assets, Valuation Allowance 944K USD -87.4%
Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent 0.21 pure +49.3%
Deferred Tax Assets, Gross 22.6M USD +15.8%
Payments to Acquire Property, Plant, and Equipment 3.07M USD +38131%
Property, Plant and Equipment, Gross 103M USD +2.83%
Operating Lease, Liability, Current 2.1M USD +32.5%
Operating Lease, Weighted Average Discount Rate, Percent 0.1 pure +100%
Deferred Income Tax Expense (Benefit) -2.5M USD -2532%
Deferred Tax Assets, Operating Loss Carryforwards 3.81M USD +123%
Additional Paid in Capital 539M USD +14.2%
Amortization of Intangible Assets 1.4M USD -12.5%
Depreciation, Depletion and Amortization 5.09M USD +21.6%
Interest Expense 17.6M USD +27.9%